Back to Pictet Asset Management Holding SA Pictet Asset Management Holding SA

IBRXIBRX
Showing 8 of 12 quarters

Position history for Pictet Asset Management Holding SAPictet Asset Management Holding SA's holdings in IMMUNITYBIO INC

Pictet Asset Management Holding SA holds 847,659 shares of IBRX (IMMUNITYBIO INC), worth $7.4M as of 2026-Q2. The position was increased (+2.1% shares). IBRX represents 0.0% of Pictet Asset Management Holding SA's portfolio.

Current Value

$7.4M

Current Shares

847,659

Total Value Change

+$7.4M

Total Shares Change

+826,103

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
847,659
+2.1%
$7.4M0.0%$8.76
28
2026-Q1
Increased
830,137
+2365.7%
$5.6M0.0%$10.00
44
2025-Q4
Unchanged
33,667
0.0%
$66,6610.0%$1.98
0
2025-Q3
Unchanged
33,667
0.0%
$82,8210.0%$2.57
0
2025-Q2
Increased
33,667
+56.2%
$88,8810.0%$2.70
31
2025-Q1
Unchanged
21,556
0.0%
$64,8840.0%$3.14
0
2024-Q4
Unchanged
21,556
0.0%
$55,1830.0%$2.68
0
2024-Q3
Unchanged
21,556
0.0%
$80,1880.0%$3.93
0

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used